PharmaCyte Biotech Inc (OTCMKTS:PMCBD – Get Free Report)’s share price was down 1.9% during trading on Friday . The stock traded as low as $1.98 and last traded at $1.98. Approximately 1,735 shares changed hands during mid-day trading, a decline of 80% from the average daily volume of 8,831 shares. The stock had previously closed at $2.02.
PharmaCyte Biotech Stock Down 1.9 %
The company has a fifty day simple moving average of $2.07 and a 200 day simple moving average of $2.14.
About PharmaCyte Biotech
PharmaCyte Biotech, Inc is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes.
See Also
- Five stocks we like better than PharmaCyte Biotech
- Election Stocks: How Elections Affect the Stock Market
- Why Call Options Volume for These 2 Stocks Spiked Together
- 10 Best Airline Stocks to Buy
- MarketBeat Week in Review – 7/22 – 7/26
- How to Use the MarketBeat Dividend Calculator
- 3M Surprises and Rebound Accelerates: It Isn’t Too Late To Get In
Receive News & Ratings for PharmaCyte Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharmaCyte Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
